Study of survivin and XIAP genes in CML revealed that disease progression from chronic to blastic phases was accompanied with overexpression of survivin [48] and XIAP mRNA levels [49, 50]. Here, BIRC5 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.